J.Adderton has 20 years experience as a MSN .
7 Followers; 44 Articles; 25,957 Visitors; 226 Posts
GLP-1 receptor agonists, such as dulaglutide (Trulicity), increase glycemic control in patients with type 2 diabetes. This article explores the added benefits of GlP-1 agonists including weight loss, A1c reduction and low risk of hypoglycemia Furthermore, the benefits of GLP-1 agonist to patients with Type 2 diabetes could help in reducing overall cardiovascular risk.
No registered users viewing this page.